Home ProductsPharmaceutical Raw Materials

APIs Pharmaceutical Raw Materials CAS 913611-97-9 Brexpiprazole Powder

Certification
Good quality Peptide APIs for sales
Good quality Peptide APIs for sales
Customer Reviews
Good Price .Product is by far the besT, very pleased and happy, wil buy again.

—— K******s United Kingdom

High Purity, fast shipping ,recomended this company.

—— Perry*****t United State

Great service I was kept informed about my order the whole time Thanks Jones.

—— E****y Australia

I'm Online Chat Now

APIs Pharmaceutical Raw Materials CAS 913611-97-9 Brexpiprazole Powder

China APIs Pharmaceutical Raw Materials CAS 913611-97-9 Brexpiprazole Powder supplier
APIs Pharmaceutical Raw Materials CAS 913611-97-9 Brexpiprazole Powder supplier

Large Image :  APIs Pharmaceutical Raw Materials CAS 913611-97-9 Brexpiprazole Powder

Product Details:

Place of Origin: China
Certification: iso

Payment & Shipping Terms:

Minimum Order Quantity: 100Grams
Price: 1
Packaging Details: Foil bag
Delivery Time: Within 1-3 Days
Payment Terms: T/T
Supply Ability: 500kgs/Month
Contact Now
Detailed Product Description

APIs Pharmaceutical Raw Materials CAS 913611-97-9 Brexpiprazole Powder

 

 

Product Name:Health & Medical Grade Brexpiprazole powder 913611-97-9 Brexpiprazole

CAS number: 913611-97-9
Molecular formula: C25H27N3O2S
Molecular weight: 433.57

Application: Used to treat schizophrenia and depression

 

 

Function Application

 

Brexpiprazole is an atypical antipsychotic drug. It is a D2 dopamine partial agonist called serotonin-dopamine activity modulator (SDAM). The drug received FDA approval on July 13, 2015 for the treatment of schizophrenia, and as an adjunctive treatment for depression. Although it failed Phase II clinical trials for ADHD, it has been designed to provide improved efficacy and tolerability (e.g., less akathisia, restlessness and/or insomnia) over established adjunctive treatments for major depressive disorder (MDD).

Get emergency medical help if you have signs of an allergic reaction: hives; difficult breathing; swelling of your face, lips, tongue, or throat.
High doses or long-term use of brexpiprazole can cause a serious movement disorder that may not be reversible. Symptoms of this disorder include uncontrollable muscle movements of your lips, tongue, eyes, face, arms, or legs. The longer you take brexpiprazole, the more likely you are to develop a serious movement disorder. The risk of this side effect is higher in women and older adults.

Contact Details
HANGZHOU MOBEL BIOTECHNOLOGY CO.,LTD

Contact Person: admin

Send your inquiry directly to us (0 / 3000)